Exact Mass: 467.0774

Exact Mass Matches: 467.0774

Found 16 metabolites which its exact mass value is equals to given mass value 467.0774, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-hydroxybenzoyl-AMP

4-Hydroxybenzoyl-adenylate; 4-Hydroxybenzoyl-AMP

C17H18N5O9P (467.0842)


   

2-hydroxybenzoyl-AMP

2-hydroxybenzoyl-AMP

C17H18N5O9P (467.0842)


   

FK-614

1-[(2,4-dichlorophenyl)methyl]-2-methyl-N-(pentane-1-sulfonyl)-1H-1,3-benzodiazole-6-carboxamide

C21H23Cl2N3O3S (467.0837)


   

3-[[4-(2,4,6-trinitroanilino)benzoyl]amino]benzoic acid

3-[[4-(2,4,6-trinitroanilino)benzoyl]amino]benzoic acid

C20H13N5O9 (467.0713)


   

2 6-DICHLORO-4-(2 4 6-TRIPHENYL-1-PYRI-&

2 6-DICHLORO-4-(2 4 6-TRIPHENYL-1-PYRI-&

C29H19Cl2NO (467.0844)


   

disodium,3-[4-[(5-nitropyridin-2-yl)diazenyl]-3-oxido-N-propylanilino]propane-1-sulfonate

disodium,3-[4-[(5-nitropyridin-2-yl)diazenyl]-3-oxido-N-propylanilino]propane-1-sulfonate

C17H19N5Na2O6S (467.0851)


   

(5AS, 10BR)-(-)-5A,10B-DIHYDRO-2-(PENTAFLUOROPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIZOLO[4,3-D][1,4]OXAZINIUM TETRAFLUOROBORATE

(5AS, 10BR)-(-)-5A,10B-DIHYDRO-2-(PENTAFLUOROPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIZOLO[4,3-D][1,4]OXAZINIUM TETRAFLUOROBORATE

C18H11BF9N3O (467.0851)


   

dimethyl 2-[[1-(4-chlorobenzoyl)-2-(trifluoromethyl)indol-3-yl]methyl]propanedioate

dimethyl 2-[[1-(4-chlorobenzoyl)-2-(trifluoromethyl)indol-3-yl]methyl]propanedioate

C22H17ClF3NO5 (467.0747)


   

2-Pentafluorophenyl-6,10b-dihydro-4H,5aH-5-oxo-3,10c-diaza-2-azoniacyclopenta[c]fluorine tetrafluoroborate

2-Pentafluorophenyl-6,10b-dihydro-4H,5aH-5-oxo-3,10c-diaza-2-azoniacyclopenta[c]fluorine tetrafluoroborate

C18H11BF9N3O (467.0851)


   

3-HYDROXY-4-(5-NITROPYRIDYLAZO)PROPYLANI

3-HYDROXY-4-(5-NITROPYRIDYLAZO)PROPYLANI

C17H19N5Na2O6S1 (467.0851)


   

1-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-1H-benzo[d]imidazole-6-carboxamide

1-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-1H-benzo[d]imidazole-6-carboxamide

C21H23Cl2N3O3S (467.0837)


FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARγ modulator (SPPARM). FK614 functions as a PPARγ agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARγ at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes[1][2].

   

N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide

N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide

C23H18FN3O3S2 (467.0774)


   

2-[[5-[[2-(3-Chloroanilino)-4-thiazolyl]methyl]-4-(3-methoxypropyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester

2-[[5-[[2-(3-Chloroanilino)-4-thiazolyl]methyl]-4-(3-methoxypropyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester

C19H22ClN5O3S2 (467.0853)


   

3-Bromo-5-[[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]-oxomethyl]-2-pyranone

3-Bromo-5-[[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]-oxomethyl]-2-pyranone

C24H22BrNO4 (467.0732)


   
   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-hydroxybenzoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-hydroxybenzoate

C17H18N5O9P (467.0842)